Last reviewed · How we verify

Comparator: naproxen sodium

Organon and Co · Phase 3 active Small molecule

Comparator: naproxen sodium is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Organon and Co. It is currently in Phase 3 development for Mild to moderate pain, Rheumatoid arthritis, Osteoarthritis. Also known as: naproxen sodium.

Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.

Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever. Used for Mild to moderate pain, Rheumatoid arthritis, Osteoarthritis.

At a glance

Generic nameComparator: naproxen sodium
Also known asnaproxen sodium
SponsorOrganon and Co
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-1, COX-2
ModalitySmall molecule
Therapeutic areaPain Management, Rheumatology, Inflammation
PhasePhase 3

Mechanism of action

Naproxen sodium blocks both COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammatory responses and pain signaling. The sodium salt formulation allows for faster absorption and more rapid onset of action compared to naproxen base. This mechanism makes it effective for acute and chronic pain relief, particularly in inflammatory conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Comparator: naproxen sodium

What is Comparator: naproxen sodium?

Comparator: naproxen sodium is a Nonsteroidal anti-inflammatory drug (NSAID) drug developed by Organon and Co, indicated for Mild to moderate pain, Rheumatoid arthritis, Osteoarthritis.

How does Comparator: naproxen sodium work?

Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.

What is Comparator: naproxen sodium used for?

Comparator: naproxen sodium is indicated for Mild to moderate pain, Rheumatoid arthritis, Osteoarthritis, Menstrual cramps, Fever.

Who makes Comparator: naproxen sodium?

Comparator: naproxen sodium is developed by Organon and Co (see full Organon and Co pipeline at /company/organon-and-co).

Is Comparator: naproxen sodium also known as anything else?

Comparator: naproxen sodium is also known as naproxen sodium.

What drug class is Comparator: naproxen sodium in?

Comparator: naproxen sodium belongs to the Nonsteroidal anti-inflammatory drug (NSAID) class. See all Nonsteroidal anti-inflammatory drug (NSAID) drugs at /class/nonsteroidal-anti-inflammatory-drug-nsaid.

What development phase is Comparator: naproxen sodium in?

Comparator: naproxen sodium is in Phase 3.

What are the side effects of Comparator: naproxen sodium?

Common side effects of Comparator: naproxen sodium include Gastrointestinal upset (nausea, dyspepsia), Abdominal pain, Headache, Dizziness, Increased cardiovascular risk (with chronic use), Renal impairment (with chronic use).

What does Comparator: naproxen sodium target?

Comparator: naproxen sodium targets COX-1, COX-2 and is a Nonsteroidal anti-inflammatory drug (NSAID).

Related